4//SEC Filing
Kraus Carl N 4
Accession 0001214659-24-004306
CIK 0001398733other
Filed
Mar 10, 8:00 PM ET
Accepted
Mar 11, 10:35 AM ET
Size
7.3 KB
Accession
0001214659-24-004306
Insider Transaction Report
Form 4
Kraus Carl N
Chief Medical Officer
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2024-03-07+56,250→ 56,250 totalExercise: $5.68Exp: 2034-03-07→ Common Stock (56,250 underlying) - Award
Common Stock
2024-03-07+112,500→ 262,500 total
Footnotes (2)
- [F1]The Common Stock is represented by restricted stock which will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment
- [F2]The options will vest in three annual installments with 25% on the 1st installment, 25% on the 2nd installment and 50% on the 3rd installment.
Documents
Issuer
Aquestive Therapeutics, Inc.
CIK 0001398733
Entity typeother
Related Parties
1- filerCIK 0001946475
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 8:00 PM ET
- Accepted
- Mar 11, 10:35 AM ET
- Size
- 7.3 KB